By The US biopharmaceutical firm Amgen said Monday it has reached agreement to acquire Horizon Therapeutics, which specializes in medicine for rare and auto-immune diseases, for $27.8 billion.
US biopharma firm Amgen to acquire Horizon Therapeutics for nearly $28 bn
smart city and communication network. Smart city dot point connect .internet of things connection metaverse technology.
Comments